Improving HIV post-exposure prophylaxis rates after pediatric acute sexual assault
- PMID: 28456065
- DOI: 10.1016/j.chiabu.2017.04.014
Improving HIV post-exposure prophylaxis rates after pediatric acute sexual assault
Abstract
The purpose of our study was to increase the rate of children with appropriate HIV-PEP regimens among those diagnosed with sexual assault in The Children's Hospital of Philadelphia Emergency Department (ED). The outcome measure was the percent of patients receiving correct HIV-PEP. We retrospectively reviewed 97 charts over 31 months to define the baseline rate of children receiving appropriate HIV-PEP regimens (pre QI-implementation period: 2/2012-8/2014). Among children in which HIV-PEP was indicated following sexual assault, 40% received the recommended 28-day course. Root cause analysis indicated prescribing errors accounted for 87% of patients not receiving appropriate HIV-PEP. Process drivers included standardizing care coordination follow-up calls to elicit specific information about HIV-PEP, ED educational initiatives targeted at HIV-PEP prescribing, revision of the clinical pathway to specify indicated duration of HIV-PEP, and revision of the order set to auto-populate the number of days for the HIV-PEP prescription. During the QI-implementation period (9/2014-4/2015), the rate of appropriate HIV-PEP increased to 64% (median 60%) and the average number of days between incorrect HIV-PEP regimens was 24.5. Post QI-implementation (5/2015-3/2016), the rate of appropriate HIV-PEP increased to 84% (median 100%) and the average number of days between incorrect HIV-PEP regimens increased to 78.4. A multifaceted quality improvement process improved the rate of receipt of appropriate HIV-PEP regimens for pediatric victims of sexual assault. Decision support tools are instrumental in sustaining ideal care delivery, but require ongoing evaluation and improvement in order to remain optimally effective.
Keywords: HIV-PEP; Order set; Pathway; Sexual assault.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern U.S. emergency department.Am J Emerg Med. 2021 Nov;49:117-123. doi: 10.1016/j.ajem.2021.05.070. Epub 2021 Jun 1. Am J Emerg Med. 2021. PMID: 34102456
-
The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study.Forensic Sci Med Pathol. 2018 Sep;14(3):332-341. doi: 10.1007/s12024-018-9985-7. Epub 2018 May 18. Forensic Sci Med Pathol. 2018. PMID: 29777425
-
Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims.Arch Pediatr Adolesc Med. 2006 Jul;160(7):674-80. doi: 10.1001/archpedi.160.7.674. Arch Pediatr Adolesc Med. 2006. PMID: 16818831
-
Postexposure prophylaxis against human immunodeficiency virus.Am Fam Physician. 2010 Jul 15;82(2):161-6. Am Fam Physician. 2010. PMID: 20642270 Review.
-
Post-exposure prophylaxis for HIV infection after sexual assault: when is it indicated?Emerg Med J. 2001 Jul;18(4):242-5. doi: 10.1136/emj.18.4.242. Emerg Med J. 2001. PMID: 11435354 Free PMC article. Review.
Cited by
-
"Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis.J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):196-200. doi: 10.1093/jpids/piaa033. J Pediatric Infect Dis Soc. 2021. PMID: 32347312 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
